###begin article-title 0
Derangement of a Factor Upstream of RARalpha Triggers the Repression of a Pleiotropic Epigenetic Network
###end article-title 0
###begin p 1
Conceived and designed the experiments: FC SR GB. Performed the experiments: FC SR GB MR. Analyzed the data: FC SR GB MR. Wrote the paper: FC SR GB NS. Conceived the hypothesis and supervised the project: NS. Contributed to finalizing the paper for submission: SR.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Chromatin adapts and responds to extrinsic and intrinsic cues. We hypothesize that inheritable aberrant chromatin states in cancer and aging are caused by genetic/environmental factors. In previous studies we demonstrated that either genetic mutations, or loss, of retinoic acid receptor alpha (RARalpha), can impair the integration of the retinoic acid (RA) signal at the chromatin of RA-responsive genes downstream of RARalpha, and can lead to aberrant repressive chromatin states marked by epigenetic modifications. In this study we tested whether the mere interference with the availability of RA signal at RARalpha, in cells with an otherwise functional RARalpha, can also induce epigenetic repression at RA-responsive genes downstream of RARalpha.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 62 67 <span type="species:ncbi:9606">human</span>
To hamper the availability of RA at RARalpha in untransformed human mammary epithelial cells, we targeted the cellular RA-binding protein 2 (CRABP2), which transports RA from the cytoplasm onto the nuclear RARs. Stable ectopic expression of a CRABP2 mutant unable to enter the nucleus, as well as stable knock down of endogenous CRABP2, led to the coordinated transcriptional repression of a few RA-responsive genes downstream of RARalpha. The chromatin at these genes acquired an exacerbated repressed state, or state "of no return". This aberrant state is unresponsive to RA, and therefore differs from the physiologically repressed, yet "poised" state, which is responsive to RA. Consistent with development of homozygosis for epigenetically repressed loci, a significant proportion of cells with a defective CRABP2-mediated RA transport developed heritable phenotypes indicative of loss of function.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
Derangement/lack of a critical factor necessary for RARalpha function induces epigenetic repression of a RA-regulated gene network downstream of RARalpha, with major pleiotropic biological outcomes.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Blomhoff1">[1]</xref>
###xml 266 269 266 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Napoli1">[2]</xref>
###xml 395 398 395 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Chambon1">[3]</xref>
###xml 852 855 840 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Dilworth1">[4]</xref>
###xml 857 860 845 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bastien1">[5]</xref>
Retinoic acid (RA), the bioactive derivative of retinol, is a signal fundamental for developmental and cellular processes, whose intracellular physiological level is tightly regulated by a complex metabolic pathway involving both RA synthesis and RA catabolism [1], [2]. RA exerts its biological action mainly by binding and activating specialized transcription factors, the RA-receptors (RARs) [3]. When RA is channeled onto the retinoic acid receptor alpha (RARalpha) in the nucleus, it can rapidly induce transcription of RARalpha-target genes containing a RA-responsive element (RARE). Specifically, RA binding to RARalpha triggers both the dissociation of corepressors proteins, and the recruitment of coactivators and histone modifying enzymes that enable chromatin conformation changes compatible with the access and action of RNA polymerase II [4], [5].
###end p 9
###begin p 10
###xml 182 190 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 297 300 283 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Chiba1">[6]</xref>
###xml 397 400 383 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bistulfi1">[7]</xref>
###xml 402 405 388 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Pozzi1">[8]</xref>
###xml 429 437 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 517 520 500 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Dilworth1">[4]</xref>
###xml 522 525 505 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bastien1">[5]</xref>
The temporal dynamics of the cascade of events following RA-RARalpha-mediated chromatin activation has been mostly derived from studies on the prototypic direct RARalpha-target gene RARbeta2. Once expressed in response to RA, RARbeta2 sustains its own transcription by binding to its own promoter [6], and subsequently activates the chromatin of other downstream RA-responsive direct target genes [7], [8]. In the absence of RA, RARbeta2 chromatin reaches a repressed state, which is however poised for transcription [4], [5].
###end p 10
###begin p 11
###xml 217 225 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 310 313 299 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Ren1">[9]</xref>
###xml 510 518 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 695 703 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 726 733 698 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 850 853 822 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Pozzi1">[8]</xref>
###xml 855 859 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Sonneveld1">[10]</xref>
###xml 1050 1058 1018 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 1102 1107 1064 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 1223 1226 1185 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bistulfi1">[7]</xref>
###xml 577 582 <span type="species:ncbi:10090">mouse</span>
###xml 891 896 <span type="species:ncbi:9606">human</span>
Previously, we demonstrated that when RA signal cannot be integrated at RARalpha, because RARalpha is either not expressed, or has acquired genetic mutations that make it non-functional, the chromatin associated with RARbeta2 falls into an aberrant exacerbated state of repression, which is unresponsive to RA [9]. Moreover, by using different cell systems, we demonstrated that the impaired integration of RA signal at a mutant RARalpha induces a repression wave that is propagated, in a domino fashion, from RARbeta2 to targets downstream of RARbeta2. Specifically, by using mouse embryocarcinoma cells, we found that a dominant negative RARalpha mutant creates a concerted repression of both RARbeta2 and its direct target CYP26A1, encoding the cytochrome P450 RA-specific hydrolase, which acts as a neuronal differentiation switch in these cells [8], [10]. In an independent study using human mammary epithelial cells, we demonstrated that inhibition of RARalpha function with various genetic strategies triggers the concerted repression of both RARbeta2 and another target downstream of RARbeta2, CRBP1, encoding the cellular retinol binding protein 1, which is pivotal for breast epithelial cell acinar morphogenesis [7].
###end p 11
###begin p 12
###xml 34 42 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 126 130 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Sirchia1">[11]</xref>
###xml 286 294 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
Based on the observation that the RARbeta2 chromatin can also be found aberrantly repressed in RARalpha-positive cancer cells [11], we hypothesized that lack/derangement of upstream factors capable of affecting RARalpha function is sufficient to induce aberrant chromatin repression at RARbeta2 and its downstream targets.
###end p 12
###begin p 13
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Budhu1">[12]</xref>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loci</italic>
###xml 526 530 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Sessler1">[13]</xref>
###xml 665 673 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
In the present study we show that the derangement of the cellular RA binding protein 2 (CRABP2), critical for the transport of RA from the cytoplasm to the RARs in the nucleus [12], can indeed trigger a long-distance chromatin repression effect at loci of an entire RARalpha-regulated epigenetic network. We found that, not only the knock down of endogenous CRABP2 by RNAi, but simply the mere interference of RA transport into the nucleus, achieved by expressing a dominant negative CRABP2 mutant unable to enter the nucleus [13], can initiate the wave of aberrant repression at the chromatin of multiple RA-responsive genes. The wave of repression involves first RARbeta2, thus affecting cell growth, and next branches downstream, to involve genes that control both RA metabolism/homeostasis and morphogenesis.
###end p 13
###begin p 14
In conclusion, interference with RA transport at RARalpha into the nucleus is sufficient to induce coordinated, heritable, chromatin repression at multiple loci of a RA-responsive gene network downstream of RARalpha, with pleiotropic biological outcomes.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Interference with RA transport into the nucleus is sufficient to induce transcriptional repression of genes downstream of RARalpha
###end title 16
###begin p 17
###xml 86 90 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Budhu1">[12]</xref>
###xml 92 96 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Jing1">[14]</xref>
###xml 98 102 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Dong1">[15]</xref>
###xml 145 152 133 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g001">Fig. 1A</xref>
###xml 171 178 159 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g001">Fig. 1A</xref>
###xml 328 337 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2,</italic>
###xml 372 377 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 409 416 383 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g001">Fig. 1B</xref>
RARalpha activation requires the transport of RA to RARalpha in the nucleus by CRABP2 [12], [14], [15]. HME1 cells, which express both RARalpha (Fig. 1A left) and CRABP2 (Fig. 1A, right), can properly integrate RA signal through RARalpha, as demonstrated by the transcriptional activation of two prototypic RA-responsive genes, RARbeta2, a downstream RARalpha target, and CRBP1, a downstream RARbeta2 target (Fig. 1B, left and right).
###end p 17
###begin title 18
Interference with RA transport into the nucleus is sufficient to induce transcriptional repression of genes downstream of RARalpha.
###end title 18
###begin p 19
###xml 290 298 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 303 308 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 982 990 970 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1133 1141 1117 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 1146 1151 1127 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
(A) WB analysis showing that HME1 cells express RARalpha (left). Immunoprecipitation (IP) followed by WB showing that HME1 express CRABP2. IP of Hela cells transiently transfected with CRABP2-V5 served as positive control (right). (B) Transcriptional activation of two RA-responsive genes, RARbeta2 and CRBP1, in response to RA (72 h) demonstrates a functional RA-RARalpha signaling in HME1 cells. (C) Transient HME1 transfection with wild type CRABP2-V5, followed by immunocytochemistry with anti-V5 (red) and DAPI nuclear staining (blue), shows that exogenous CRABP2-V5 can translocate from the cytoplasm into the nucleus after treatment with 0.1 muM RA for 30 min. (left). In contrast, exogenous CRABP2-KRK-V5 mutant carrying a mutated nuclear localization signal (NLS) is not able to enter the nucleus under the same conditions (right). (D) WB analysis showing the expression of the CRABP2-KRK-V5 protein in the HME1-derived clone KRK-15, but not in the HME1 control clone EV7. In vitro transcribed and translated CRABP2-KRK-V5 was used as a positive control (left). Both KRK-15 and EV-7 cells express RARalpha (right). (E) Both RARbeta2 and CRBP1 transcription are significantly less inducible by RA (72 h) in KRK-15 cells relative to the control EV7 cells.
###end p 19
###begin p 20
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Sessler1">[13]</xref>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Sessler1">[13]</xref>
###xml 553 560 552 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g001">Fig. 1C</xref>
To transport RA into the nucleus, CRABP2 requires a specific nuclear localization signal (NLS) [13]. A mutant CRABP2-KRK protein, which was shown to bind RA with affinity similar to the one of the wild type CRABP2 protein, cannot transport RA into the nucleus due to critical mutations in the NLS [13]. Indeed, by using immunocytochemistry, we found that the V5-tagged CRABP2-KRK protein, transiently expressed in HME1 cells, differently from the wild type CRABP2-V5 protein, is not able to enter the nucleus after addition of RA (0.1 muM, 30 minutes) (Fig. 1C).
###end p 20
###begin p 21
###xml 188 195 188 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g001">Fig. 1D</xref>
###xml 297 304 293 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g001">Fig. 1D</xref>
###xml 479 487 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 492 497 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 564 571 557 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g001">Fig. 1E</xref>
Next, we tested whether RA transport into the nucleus is hampered in CRABP2-KRK-positive cells. Stable expression of the CRABP2-KRK-V5 protein in HME1 cells (shown for the KRK-15 clone in Fig. 1D, left), while not affecting the expression of endogenous RARalpha relative to the control clone EV7 (Fig. 1D, right), clearly exerts a dominant negative effect over the endogenous CRABP2. This conclusion is based on the observation that RA-induced transcriptional activation of both RARbeta2 and CRBP1 is reduced in the KRK-15 clone relative to the control clone EV7 (Fig. 1E, left and right). Thus, targeting CRABP2 function prevents RARalpha function and affects, in a negative and irreversible fashion, the transcriptional status of RA-responsive genes downstream of RARalpha.
###end p 21
###begin title 22
Evidence of chromatin repression at RA-responsive genes downstream of RARalpha consequent to CRABP2 knock-down
###end title 22
###begin p 23
###xml 131 139 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 144 149 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 224 230 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRABP2</italic>
###xml 281 289 278 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004305.s001">Fig. S1A</xref>
###xml 393 401 390 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004305.s001">Fig. S1A</xref>
###xml 526 534 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004305.s001">Fig. S1B</xref>
###xml 358 363 <span type="species:ncbi:9606">human</span>
To test whether targeting endogenous CRABP2 in HME1 cells can indeed induce heritable aberrant repression of the chromatin at both RARbeta2 and CRBP1, we knocked down CRABP2 by stable RNA interference with either one of two CRABP2-targeting shRNA sequences, CRABP2-A and CRABP2-C (Fig. S1A). A scrambled (mock) shRNA sequence, which should not recognize any human mRNA, was used as a control (Fig. S1A). Only the shRNAs sequences directed against CRABP2 were shown to efficiently decrease exogenous CRABP2 protein expression (Fig. S1B).
###end p 23
###begin p 24
###xml 214 222 214 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004305.s001">Fig. S1C</xref>
###xml 319 326 319 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g002">Fig. 2A</xref>
###xml 385 392 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g002">Fig. 2A</xref>
###xml 450 458 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 463 468 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 496 503 489 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g002">Fig. 2B</xref>
We further tested two CRABP2 knock down clones, Si-CRABP2-A6, carrying the CRABP2-A sequence, and Si-CRABP2-C6, carrying the CRABP2-C sequence, along with the control clone Mock13, carrying the scrambled sequence (Fig. S1C). Both Si-CRABP2-A6 and Si-CRABP2-C6 displayed a significant decrease of the CRABP2 transcript (Fig. 2A, left), while they still expressed the RARalpha receptor (Fig. 2A, right). RA failed to activate the transcription of both RARbeta2 and CRBP1 in both knock down clones (Fig. 2B, left and right).
###end p 24
###begin title 25
Evidence of chromatin repression at RA-responsive genes downstream of RARalpha consequent to CRABP2 knock-down.
###end title 25
###begin p 26
###xml 194 200 194 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRABP2</italic>
###xml 379 387 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 399 404 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 605 613 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 624 629 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 815 823 805 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 834 839 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 1063 1071 1050 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 1082 1087 1066 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
(A) The HME1-derived stable clones Si-CRABP2-A6 and Si-CRABP2-C6, carrying two distinct CRABP2-targeting shRNA sequences (CARBP2-A and CRABP2-C, respectively), display a significant decrease in CRABP2 transcript relative to the control clone Mock-13 (left). The level of RARalpha expression is similar in Si-CRABP2-A6, Si-CRABP2-C6 and the control clone Mock13 (right). (B) Both RARbeta2 (left) and CRBP1 (right) are significantly less inducible by RA (72 h) in Si-CRABP2-A6 and Si-CRABP2-C6 clones relative to the control Mock13 clone. (C) qChIP analysis with anti-acetyl histone H4 (Ac-H4) showing that RARbeta2 (top) and CRBP1 (bottom) chromatin of both Si-CRABP2-A6 and Si-CRABP2-C6 is marked by H4 hypoacetylation at the RARE-containing regulatory regions relative to the control clone Mock-13. (D) RA-induced RARbeta2 (top) and CRBP1 (bottom) transcription can be restored in Si-CRABP2-A6 cells by treatment with the HDAC inhibitor TSA. (E) qChIP with anti-Polymerase II (Pol II) showing decreased occupancy of Pol II at the RARE-containing regions of both RARbeta2 (top) and CRBP1 (bottom) in Si-CRABP2-A6 and Si-CRABP2-C6.
###end p 26
###begin p 27
###xml 184 192 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 205 210 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 217 224 214 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g002">Fig. 2C</xref>
###xml 277 285 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 290 295 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 490 497 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g002">Fig. 2D</xref>
###xml 633 641 627 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 651 656 642 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 727 734 718 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g002">Fig. 2E</xref>
Moreover, ChIP analysis with anti-acetylated histone H4 (Ac-H4) showed significant hypoacetylation, which remained unresponsive to RA, of the chromatin regions encompassing either the RARbeta2-RARE or the CRBP1-RARE (Fig. 2C, top and bottom). Apparently, the chromatin at both RARbeta2 and CRBP1 was converted from a state poised for transcription to an exacerbated repressed state unresponsive to RA, which could be reverted only by treatment with the HDAC inhibitor Trichostatin A (TSA) (Fig. 2D, top and bottom). This conclusion was consistent with ChIP analysis with an anti-RNA Polymerase II (Pol II) antibody showing that both RARbeta2-RARE and CRBP1-RARE chromatin regions have become inaccessible to RNA Polymerase II (Fig. 2E, top and bottom).
###end p 27
###begin p 28
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loci</italic>
Thus, as a consequence of CRABP2 knock down, the chromatin of two loci downstream of RARalpha has acquired a repressed "state of no return", unresponsive to RA. This state, non-permissive for transcription, differs from the poised state, responsive to RA, which is permissive for transcription.
###end p 28
###begin title 29
###xml 122 130 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 135 140 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
Hampering CRABP2 function in HME1 cells leads to biological phenotypes that reflect homozygosis for epigenetically silent RARbeta2 and CRBP1 alleles
###end title 29
###begin p 30
###xml 67 75 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 141 144 138 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bistulfi1">[7]</xref>
###xml 146 153 143 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g003">Fig. 3A</xref>
###xml 346 353 343 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g003">Fig. 3A</xref>
###xml 388 396 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 500 508 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 580 587 571 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g003">Fig. 3B</xref>
###xml 633 638 624 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 707 710 698 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bistulfi1">[7]</xref>
###xml 712 719 703 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g003">Fig. 3C</xref>
###xml 903 910 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g003">Fig. 3C</xref>
###xml 1068 1073 1059 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 1145 1152 1136 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g003">Fig. 3D</xref>
We previously demonstrated that knock down of the tumor suppressor RARbeta2 in HME1 cells confers resistance to RA-induced growth inhibition [7] (Fig. 3A, left). Analysis of RA-resistance by colony formation in HME1-derived clones with either ectopic expression of CRABP2-KRK (CRABP2-KRK15), or CRABP2 knock down (Si-CRABP2-A6 and Si-CRABP2-C6) (Fig. 3A, right) clearly indicated loss of RARbeta2 function. RA-resistance is expected only in association with homozygous repression of the chromatin at RARbeta2 alleles, which are consequently non permissive (np) for transcription (Fig. 3B). Similarly, we previously demonstrated that CRBP1 knock down in HME1 cells hampers acinar morphogenesis in 3D culture [7] (Fig. 3C). We observed aberrant acinar morphology also in HME1-derived clones with either ectopic expression of CRABP2-KRK (CRABP2-KRK15) or CRABP2 knock down (Si-CRABP2-A6 and Si-CRABP2-C6) (Fig. 3C), thus indicating loss of CRBP1 function. Loss of proper acinar morphogenesis is expected only in association with homozygous repression of the chromatin at CRBP1 alleles, which are consequently non permissive (np) for transcription (Fig. 3D).
###end p 30
###begin title 31
###xml 122 130 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 135 140 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
Hampering CRABP2 function in HME1 cells leads to biological phenotypes that reflect homozygosis for epigenetically silent RARbeta2 and CRBP1 alleles.
###end title 31
###begin p 32
###xml 394 402 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 503 511 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 577 585 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 1131 1136 1116 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
(A) HME1 cells knocked down for RARbeta2 (Si-RARbeta2) develop resistance to RA growth-inhibitory action (left). The HME1 clones KRK-15, Si-CRABP2-A6 and Si-CRABP2-C6, with impaired CRABP2 function, show a significantly higher fraction of RA-resistant cells than the cognate control clones EV7 and Mock-13 (right). (B) Scheme showing that RA-resistance is expected only in cells homozygous for RARbeta2 alleles non-permissive for transcription (np/np), but not in cells either homozygous for permissive RARbeta2 alleles (p/p), or heterozygous for permissive and non-permissive RARbeta2 alleles (p/np). (C) HME1 cells knocked down for CRBP1 (Si-CRBP1, top left) are unable to form hollow, polarized acini in three-dimensional (3D) culture, as shown by confocal fluorescence microscopy (nuclei are visualized in blue, integrin in green, and the Golgi apparatus in red). HME1 clones with an impaired CRABP2 function (KRK15, Si-CRABP2-A6 and Si-CRABP2-C6) are also unable of proper acinar morphogenesis. (D) Scheme showing that impaired acinar morphogenesis is expected only in cells that have developed homozygosis for non-permissive CRBP1 alleles.
###end p 32
###begin p 33
###xml 247 255 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 260 270 257 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1 loci</italic>
Interference with CRABP2 function apparently induces loss of both RA-induced growth inhibition and 3D-acinar morphogenesis in a significant fraction of cells, strongly suggesting the occurrence of heritable homozygous epigenetic silencing at both RARbeta2 and CRBP1 loci.
###end p 33
###begin title 34
###xml 103 111 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 116 121 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
Evidence of CpG hypermethylation corroborates the occurrence of heritable epigenetic silencing at both RARbeta2 and CRBP1 consequent to deranged CRABP2 function
###end title 34
###begin p 35
###xml 121 129 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 134 139 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 337 345 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 350 355 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 371 378 365 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g004">Fig. 4A</xref>
###xml 469 477 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 482 487 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 604 612 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 687 695 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 718 721 703 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Ren1">[9]</xref>
###xml 733 738 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 806 811 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 952 955 933 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bistulfi1">[7]</xref>
###xml 1049 1057 1030 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 1062 1067 1040 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 1129 1136 1107 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g004">Fig. 4B</xref>
###xml 1172 1180 1150 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 1185 1190 1160 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 1367 1375 1342 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 1380 1385 1352 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
DNA hypermethylation is an epigenetic and heritable modification. For this reason, we tested for DNA hypermethylation at RARbeta2 and CRBP1 in HME1 cells with deranged CRABP2 function. First, we found that treatment of Si-CRABP2-A6 cells with the demethylating agent 5-aza-2'-deoxycitidine (5-Aza) could significantly restore RA-induced RARbeta2 and CRBP1 transcription (Fig. 4A, left and right). Then, we tested by quantitative methylation specific PCR (qMSP) whether RARbeta2 and CRBP1 regulatory regions in the CRABP2 knock down clones were indeed marked by DNA hypermethylation. For the detection of RARbeta2 methylated (M) alleles, we used primers previously shown to recognize the RARbeta2 methylation epicenter [9], while for CRBP1 we used primers recognizing the two regions, M1 and M2, within the CRBP1 CpG island that we demonstrated previously to be the first undergoing aberrant DNA methylation in cells with an impaired RARalpha signaling [7]. This analysis clearly shows that CRABP2 knock down clones A6 and C6 have significantly more RARbeta2 and CRBP1 methylated (M) alleles relative to the control clone Mock13 (Fig. 4B, left and right). The finding that RARbeta2 and CRBP1 silencing is associated with DNA hypermethylation, a well-established hallmark of aberrantly repressed chromatin, further reinforces our conclusion that the repressed state of RARbeta2 and CRBP1 chromatin in cells with deranged CRABP2 function is heritable, and therefore epigenetic.
###end p 35
###begin title 36
###xml 93 101 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 106 111 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
Evidence of CpG hypermethylation corroborates the occurrence of epigenetic silencing at both RARbeta2 and CRBP1 consequent to impaired CRABP2 function.
###end title 36
###begin p 37
###xml 101 109 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 114 119 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 264 272 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 284 289 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
(A) Treatment with the demethylating agent 5-Aza can restore RA-induced transcription from repressed RARbeta2 and CRBP1 chromatin in Si-CRABP2-A6 cells (left and right, respectively). (B) Quantitative MSP detecting methylated (M) alleles shows hypermethylation of RARbeta2 (left) and CRBP1 (right) CpG-rich regulatory regions in Si-CRABP2-A6 and Si-CRABP2-C6 clones.
###end p 37
###begin title 38
Derangement of CRABP2 function exerts a chromatin repression effect branching downstream of RARbeta2
###end title 38
###begin p 39
###xml 233 241 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 246 254 239 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1,</italic>
###xml 309 312 302 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Pozzi1">[8]</xref>
###xml 448 455 437 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004305.s002">Fig. S2</xref>
###xml 523 530 512 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
We previously demonstrated in a mouse embryonic carcinoma cell model that an endogenous dominant negative RARalpha mutant, lacking part of the E domain harboring the RA-binding domain, induced concerted epigenetic repression of both RARbeta2 and CYP26A1, encoding for a RA hydrolase involved in RA catabolism [8]. We reproduced this finding also in human cells carrying an exogenous dominant negative RARalpha mutant lacking the RA-binding domain (Fig. S2). Here we show that hampering CRABP2 function leads to significant CYP26A1 chromatin repression also in HME1 cells.
###end p 39
###begin p 40
###xml 184 191 184 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 207 214 207 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g005">Fig. 5A</xref>
###xml 247 254 247 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Loudig1">[16]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Loudig2">[17]</xref>
###xml 480 487 480 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 719 726 719 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g005">Fig. 5B</xref>
###xml 824 831 824 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 906 913 906 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g005">Fig. 5B</xref>
First, we found that impairment of CRABP2 function in HME1 cells by either CRABP2 knock down, or expression of the mutant CRABP2-KRK, leads to significant downregulation of RA-induced CYP26A1 transcription (Fig. 5A, left and right, respectively). CYP26A1 transcription is driven by a promoter region containing a proximal RARE at -87 and seems to be enhanced by an upstream region containing a distal RARE at -1973 [16], [17]. ChIP analysis with anti-acetyl histone H4 shows that CYP26A1 downregulation in Si-CRABP2-A6 and Si-CRABP2-C6 clones is marked by histone deacetylation, which is unresponsive to RA, both in the region containing the distal RARE (data not shown) and in the region containing the proximal RARE (Fig. 5B, left). Consistently, treatment with the HDAC inhibitor TSA could efficiently restore RA-induced CYP26A1 transcription in CRABP2 knock down clones (shown here for Si-CRABP2-A6 in Fig. 5B, right).
###end p 40
###begin title 41
Derangement of CRABP2 function exerts a chromatin repression effect branching downstream of RARbeta2.
###end title 41
###begin p 42
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 487 494 487 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 528 535 528 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP16A1</italic>
###xml 1068 1074 1068 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2A1</italic>
###xml 1154 1161 1154 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 1287 1294 1287 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 1389 1396 1389 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 1444 1449 1444 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
(A) RA-induced transcription of CYP26A1 is significantly downregulated in both HME1 cells knocked down for CRABP2 (Si-CRABP2-A6 and Si-CRABP2-C6 clones, left), and HME1 cells carrying the CRABP2-KRK mutant (KRK-15 clone, right) relative to control cells (Mock 13 and EV7 clones, respectively). (B) qChIP analysis with anti-acetyl histone H4 showing that CYP26A1 chromatin in Si-CRABP2-A6 and Si-CRABP2-C6 clones is marked by a significant H4 hypoacetylation of a region encompassing the CYP26A1 proximal RARE (left). RA-induced CYP16A1 transcription can be restored in Si-CRABP2-A6 by treatment with the HDAC inhibitor TSA for 72 h (right). (C) Bisulfite sequencing showing that HME1, like the CYP26A1-positive cell line T47D, is unmethylated in the proximal RARE-containing CpG island, while the CYP26A1-negative cell line MDA-MB-231 is fully methylated (left). Quantitative MSP with primers recognizing only methylated (M) alleles can detect methylation in MDA-MB-231, but not in T47D or HME1 cells (right). (D) Quantitative MSP analysis showing hypermethylation of CYP2A1 proximal CpG island in Si-CRABP2-A6 and Si-CRABP2-C6 clones (left). RA-induced CYP26A1 transcription can be efficiently restored in Si-CRABP2-A6 cells by treatment with the demethylating agent 5-Aza (right). (E) CYP26A1 transcription can still be induced by RA in HME1 cells knock down for CRBP1 (Si-CRBP1). Thus, CYP26A1 epigenetic downregulation is not consequent to CRBP1 epigenetic silencing.
###end p 42
###begin p 43
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 142 151 142 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 199 207 199 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1,</italic>
###xml 323 330 323 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004305.s003">Fig. S3</xref>
###xml 559 566 559 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g005">Fig. 5C</xref>
###xml 927 934 927 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g005">Fig. 5C</xref>
###xml 1011 1018 1011 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 1080 1087 1080 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g005">Fig. 5D</xref>
###xml 1194 1201 1194 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 1275 1282 1275 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g005">Fig. 5D</xref>
###xml 193 198 <span type="species:ncbi:9606">human</span>
Second, we tested whether the CYP26A1 repressed chromatin state, consequent to CRABP2 knock down, was also marked by DNA hypermethylation. By in silico analysis of the 5' regulatory regions of human CYP26A1, we identified two canonical CpG islands: one encompassing the distal RARE, and one encompassing the proximal RARE (Fig. S3). Bisulfite sequencing of these two regions showed that the proximal CpG island is fully methylated in the CYP26A1-negative cell line MDA-MB-231, while it is fully unmethylated in two CYP26A1-positive cell lines, T47D and HME1 (Fig. 5C, left). In contrast, the methylation status of the distal CpG island did not show any significant difference between HME1 and MDA-MB-231 (data not shown). Therefore, we focused our analysis on the proximal CpG island. By using qMSP with primers able to discriminate between the different methylation status of the control cell lines HME1, T47D and MDA-MB-231 (Fig. 5C, right), we found that the CRABP2 knock down clones have significantly more CYP26A1 methylated (M) alleles relative to the control clone Mock13 (Fig. 5D, left). Consistently, treatment with the demethylating agent 5-Aza could significantly restore RA-induced CYP26A1 transcription in CRABP2 knock down cells (shown here for Si-CRABP2-A6 in Fig. 5D, right).
###end p 43
###begin p 44
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 132 138 132 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1,</italic>
###xml 180 187 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 273 280 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g005">Fig. 5E</xref>
###xml 289 296 286 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 474 479 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 484 491 478 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 503 509 497 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g006">Fig. 6</xref>
Finally, we asked whether CYP26A1 epigenetic downregulation is consequent to, or concomitant with, the epigenetic downregulation of CRBP1, the other RARbeta2 target. We found that CYP26A1 transcription is still RA-inducible in HME1 cells knocked down for CRBP1 (Si-CRBP1) (Fig. 5E). Thus, CYP26A1 transcriptional downregulation, induced by hampering CRABP2 function, is consequent to a "long distance" repression effect, branching downstream of RARbeta2, and involving both CRBP1 and CYP26A1 chromatin (Fig. 6).
###end p 44
###begin title 45
Epigenetic repression of a pleiotropic gene network as a consequence of a defective RA transport onto RARalpha.
###end title 45
###begin p 46
 (A) RA transport onto RARalpha by CRABP2 enables the transcriptional activation of a RA-responsive gene network involved in retinol (ROH)-RA metabolism, control of cell growth, and morphogenesis. (B) Interference with CRABP2-mediated RA transport onto RARalpha leads to epigenetic repression of this gene network, with pleiotropic biological outcome.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 324 327 312 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bistulfi1">[7]</xref>
###xml 328 331 316 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Ren1">[9]</xref>
In different cell systems, and using different mechanistic approaches, we previously demonstrated that an impaired RARalpha signalling, due to derangement/loss of RARalpha itself, confers an exacerbated repressed chromatin state, marked by repressive epigenetic changes at several RA-responsive genes downstream of RARalpha [7]-[9]. This study shows that hampering CRABP2, a factor critical for RA transport onto nuclear RARalpha, in cells with a functionally intact RARalpha, also leads to epigenetic repression of RA-responsive genes downstream of RARalpha, with heritable biological outcomes.
###end p 48
###begin p 49
###xml 138 146 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 185 190 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 195 202 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 312 318 298 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRABP2</italic>
###xml 590 596 572 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004305-g006">Fig. 6</xref>
We provide evidence that derangement of CRABP2 function is sufficient to trigger the coordinated repression of the RARalpha direct target RARbeta2, and two RARbeta2 downstream targets, CRBP1 and CYP26A1. Specifically, in HME1 cells with functional RARalpha, we observed that not only the silencing of endogenous CRABP2, but the mere interference with CRABP2-mediated RA-transport into the nucleus, achieved by expressing the CRABP2-KRK protein with a mutated nuclear localization signal, induces heritable epigenetic changes at genes of a RA-responsive gene network downstream of RARalpha (Fig. 6).
###end p 49
###begin p 50
###xml 62 65 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR</italic>
###xml 528 531 512 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Ren1">[9]</xref>
Apparently, the abrogation of RARalpha function, be it due to RARalpha silencing/genetic mutations, or derangement of a factor upstream of RARalpha (e.g. CRABP2), results in the conversion of the chromatin of RARalpha-regulated genes from an inactive, yet poised, state permissive for transcription into an exacerbated repressed state that is non permissive for transcription. We refer to the latter state as the "state of no return", because it is marked by repressive epigenetic modifications, which remain unresponsive to RA [9]. This exacerbated, repressed state is distinct from the physiological repressed poised state, which is still responsive to RA. We still do not know what molecular mechanism(s) is capable of "invoking" the recruitment of chromatin repressive activities at RA-responsive genes downstream of RARalpha, once RARalpha function is impaired.
###end p 50
###begin p 51
###xml 572 578 565 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRABP2</italic>
###xml 945 953 931 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 958 963 941 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 1122 1130 1105 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 1135 1140 1115 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 1238 1245 1218 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 1334 1341 1307 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 1472 1479 1445 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
As a result of derangement of CRABP2 function, and consequent impairment of RARalpha function, we found evidence that cells develop homozygosis for epigenetically silent genes that are either RA-receptors (RARbeta2) or RA-responsive genes involved in both RA metabolism and morphogenesis (CRBP1 and CYP26A1). Specifically, we demonstrated that the homozygous epigenotypes for these repressed genes are heritable based on the analysis of biological and morphological phenotypes in HME1 cells either carrying the dominant negative mutant CRABP2 protein, or knocked down for CRABP2. Even when RARalpha was still expressed, we observed in a significant fraction of cells both RA resistance, indicative of loss of RARbeta2 function, and aberrant acinar morphogenesis, indicative of loss of CRBP1 function. The RA-resistant phenotype and the aberrant acinar morphology is expected to reflect only epigenotypes homozygous for repressed, non-permissive RARbeta2 and CRBP1 alleles, respectively. Consistently, in the same cells, we found evidence of aberrant CpG methylation, an epigenetic hallmark of repressed chromatin, at both RARbeta2 and CRBP1. The repressive repercussion due to derangement of CRABP2 function affects also the chromatin of CYP26A1, another RA-responsive gene downstream of both RARalpha and RARbeta2. Downregulation of CYP26A1 transcription is marked by both hypoacetylation unresponsive to RA and hypermethylation of the CpG island containing the proximal CYP26A1 RARE. Apparently, RARs and genes of the RA metabolism (CRBP1 and CYP26A1), are part of the same network. This RARalpha-regulated gene network is clearly implicated also in cell growth and cell morphogenesis. Further, this gene network can undergo concerted epigenetic repression as a consequence of derangement of factor(s) capable of interfering with RARalpha function.
###end p 51
###begin p 52
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Baylin1">[18]</xref>
In conclusion, this study reinforces the supposition that epigenetic repression in cancer cells may result from an ordered, rather than random, re-programming of the chromatin in response to intrinsic and extrinsic cues; which mirrors the order that underlies development [18].
###end p 52
###begin title 53
Materials and Methods
###end title 53
###begin title 54
Cell cultures
###end title 54
###begin title 55
Cells
###end title 55
###begin p 56
###xml 334 337 331 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bistulfi1">[7]</xref>
###xml 548 551 541 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Ren1">[9]</xref>
###xml 726 727 713 714 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 166 172 <span type="species:ncbi:9913">bovine</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
The human immortalized, non-transformed breast epithelial cell strain hTERT-HME1, here referred to as HME1, was grown in Mammary Epithelial Growth Medium (MEGM) plus bovine pituitary extract as per manufacturer's instructions (Lonza, Walkersville, MD). The HME1-derived clones knock down for RARbeta2 and CRBP1 have been described in [7]. The human breast cancer cell lines T47D and MDA-MB-231 (ATCC, Manassas, VA), and the T47D-derived clones DNC8 and LXC5, carrying the dominant negative RARalpha 403, or the cognate control vector, respectively [9], were cultured in Dulbecco's modified Eagle's medium (DMEM, Invitrogen), supplemented with 5% FBS (Invitrogen, Carlsbad, CA). Cells were all maintained at 37degreesC in 5% CO2 and 85% humidity.
###end p 56
###begin title 57
Three dimensional (3D)-cultures
###end title 57
###begin p 58
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Debnath1">[19]</xref>
###xml 557 561 <span type="species:ncbi:9925">goat</span>
###xml 818 822 <span type="species:ncbi:9925">goat</span>
###xml 828 833 <span type="species:ncbi:10090">mouse</span>
###xml 880 884 <span type="species:ncbi:9925">goat</span>
###xml 890 893 <span type="species:ncbi:10116">rat</span>
HME1 cells and derived clones were grown on reconstituted basement membrane (Matrigel) to induce breast epithelial differentiation into acini-like structures, essentially as described [19]. Briefly, single cells were induced to form acini on chamber slides coated with growth factor-reduced Matrigel (BD Biosciences, San Jose, CA) in medium plus 2% matrigel for 10-15 days. After fixation with 4% paraformaldehyde for 20 min, permeabilization with Phosphate Buffered Saline (PBS) plus 0.1 % Triton X100 for 10 minutes, and blocking with PBS plus 1% BSA, 1% goat serum, 0.05 Tween 20 for 2 h, cells were incubated over night with both an antibody specific for the Golgi apparatus (anti-GM 130, 1:400, BD Biosciences), and an antibody for integrin (anti-CD49f, 1:200, Chemicon, Temecula, CA), followed by detection with goat anti-mouse Alexa Fluor 546 (1:400, Molecular Probes) and goat anti-rat Alexa Fluor 488 (1:400, Molecular Probes, Eugene, OR). Nuclei were counterstained with 300 nM DAPI (Sigma, St. Louis, MO). 30 acini, or more, per each clone were analyzed by confocal microscopy (SP2 Spectral Confocal Microscope, Leica, Wetzlar, DE) to inspect for the presence of a hollow lumen and apicobasal polarization. The morphology observed in 70% or more of the acini was considered to be the prevalent phenotype.
###end p 58
###begin title 59
Colony formation assay
###end title 59
###begin p 60
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 561 562 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Exponentially growing cells were seeded at 3x102 cells/well in 6-well plates and allowed to attach for 48 h. After treatment with either 0.1 muM RA or vehicle (ethanol) for 24 h, the medium was replaced with drug-free medium and cells were allowed to grow until the appearance of colonies was observed (10-14 days). Colonies fixed with methanol and stained with Giemsa were analyzed with Image J software () to establish the percentage of growth compared to the non-treated control (colony formation index). Statistical significance was calculated by Student's t-test on three independent determinations; p values at least <0.05 were considered as significant.
###end p 60
###begin title 61
Transient transfections
###end title 61
###begin p 62
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Sessler1">[13]</xref>
###xml 253 283 253 283 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCC ACC ATG CCC TTC TCT-3&#8242;</named-content>
###xml 296 329 296 329 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CTC TCG GAC GTA GAC CCT GG-3&#8242;</named-content>
###xml 941 945 <span type="species:ncbi:9925">goat</span>
###xml 1092 1097 <span type="species:ncbi:10090">mouse</span>
Wild type (WT) CRABP2 was amplified from pCMV-FLAG-CRABP2 plasmid DNA and CRABP2-KRK was amplified from pSG5-CRABP2-KRK plasmid DNA (kindly provided by Dr. Noa Noy, Case Western Reserve University, Cleveland, OH) [13], by using specific primers (sense: 5'- GCC ACC ATG CCC TTC TCT-3'; antisense: 5'- CTC TCG GAC GTA GAC CCT GG-3'). Both WT-CRABP2 and CRABP2-KRK amplified products were cloned into pcDNA3.1-V5/His TOPO vector (Invitrogen) in frame with the V5-His tag at the 3' end, and sequenced. HME1 cells grown on glass coverslips in 6-well plates for 24 h were transfected with either pcDNA3.1-WT-CRABP2-V5 or pcDNA3.1-CRABP2-KRK-V5 using Lipofectamine 2000 (Invitrogen) as per manufacturer's instructions. After 24 h cells were treated with either RA (0.1 muM) or vehicle (ethanol) for 30 minutes, fixed in 4% paraformaldehyde for 7 min., permeabilized with PBS plus 0.1% Triton X100 for 5 min., blocked with PBS containing 1% BSA, 1% goat serum and 0.05% Tween 20, and incubated with anti-V5 antibody (1:200) (Invitrogen) as primary antibody for 1 h, rinsed, and detected with an anti-mouse Alexa Fluor 546 secondary antibody (1:400) (Invitrogen). After counterstaining with DAPI, cells were mounted with Vectashield (Vector Laboratories), and analyzed with a Fluorescence microscope (Axioskop, Zeiss).
###end p 62
###begin title 63
Stable transfections
###end title 63
###begin p 64
###xml 242 273 242 273 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCC ACC ATG CCC TTC TCT- 3&#8242;</named-content>
###xml 293 327 293 327 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CTC TCG GAC GTA GAC CCT GG- 3&#8242;</named-content>
Cells were transfected with either pcDNA3.1-CRABP2-KRK or the cognate empty vector (EV) by using Lipofectamine 2000, and selected with 1mg/ml G-418 sulfate (Invitrogen). The presence of CRAPB2-KRK mutant was tested both by PCR (sense primer: 5'- GCC ACC ATG CCC TTC TCT- 3'; antisense primer: 5'- CTC TCG GAC GTA GAC CCT GG- 3') and Western Blotting in independent clones.
###end p 64
###begin title 65
Stable RNA interference (RNAi)
###end title 65
###begin p 66
###xml 24 56 24 56 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CTG ACC AAC GAT GGG GAA C-3&#8242;</named-content>
###xml 69 101 69 101 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGT TGT CCC TGG ACT TGT C-3&#8242;</named-content>
###xml 179 185 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRABP2</italic>
###xml 223 255 223 255 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- ACG TAC GTA CGT AGT GGG G-3&#8242;</named-content>
###xml 624 627 624 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bistulfi1">[7]</xref>
###xml 287 292 <span type="species:ncbi:9606">human</span>
The sequences CRABP2-A (5'- CTG ACC AAC GAT GGG GAA C-3'), CRABP2-C (5'- GGT TGT CCC TGG ACT TGT C-3') (Gene Bank NM_001878, nucleotides 477-495, and 9-27 respectively) targeting CRABP2 mRNA, and the control mock sequence (5'- ACG TAC GTA CGT AGT GGG G-3'), which does not recognize any human mRNA, were cloned into the pSUPER-retro vector according to the manufacturer's instructions (Oligoengine, Seattle, WA). The silencing efficiency of the short hairpin RNAs (shRNAs) produced by these constructs was preliminary tested on exogenous CRABP2 transiently cotransfected with the shRNAs in COS cells as previously described [7]. The pSuper-CRABP2-A, pSuper-CRABP2-C, and pSuper-Mock constructs were stably transfected in HME1 cells by using Lipofectamine Plus (Invitrogen). Single stable clones were selected in puromycin 1 mug/ml, tested for the presence of the correct construct by PCR and sequencing, and further analyzed for the level of endogenous CRABP2 transcript by Real Time RT-PCR.
###end p 66
###begin title 67
Drugs and treatments
###end title 67
###begin p 68
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 247 251 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Kikuchi1">[20]</xref>
###xml 303 306 299 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Ren1">[9]</xref>
###xml 573 580 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
All-trans-retinoic acid (RA) (Sigma, St. Louis, MO), 5-aza-2'-deoxycitidine (5-Aza) (Sigma), Trichostatin A (TSA) (Sigma), and a specific RARalpha antagonist ER50891 (a kind gift of Kouichi Kikuchi, Discovery Research Laboratories, Ibaraki, Japan [20]) were dissolved and stored as described previously [9]. Drugs were diluted in MEGM for HME1 cells and derived clones, or DMEM plus 5% charcoal-stripped FBS (Invitrogen) for T47D cells and derived clones. Cells were allowed to attach over night and treated in the dark with different drug combinations as indicated in the Results section. RA-treatment was performed for 24 h for colony formation assays, and for 72 h for transcription assays, adding fresh RA every 24 h. ER50891 treatment was for 24 h, while TSA and 5-Aza treatments were for 72 h.
###end p 68
###begin title 69
Protein Assays
###end title 69
###begin title 70
SDS PAGE and Western Blot (WB)
###end title 70
###begin p 71
###xml 215 223 211 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Proteins were resolved by SDS-PAGE, blotted on nitrocellulose membrane, and incubated with primary antibodies for GAPDH, RARalpha (both from Santa Cruz Biotechnology, Santa Cruz, CA), or the V5 tag (Invitrogen).The in vitro transcription/translation of CRABP2-V5 was performed using PROTEINscript(R) II kit (Ambion, Austin, TX) as per manufacturer's instructions. Primary antibodies were detected with appropriate HRP-conjugated secondary antibodies (GE Healthcare, Piscataway, NJ) and followed by ECL (GE Healthcare).
###end p 71
###begin title 72
Immunoprecipitation (IP)
###end title 72
###begin p 73
500 mul cell lysates (lysis buffer: 20 mM Hepes pH 8.0, 5mM EDTA, 150 mM NaCl, 0.5% Triton X100, 0.05% Tween20 plus Complete protease inhibitor cocktail, Roche) were pre-cleared with 40 mul proteinA/proteinG slurry (2/1 by vol.) (Sigma), then incubated over night with anti-CRABP2 antibody. CRABP2-antibody complexes were immunoprecipitated by adding 40 mul proteinA/proteinG slurry (2/1 by vol.), washed, eluted with Laemmli sample buffer and analyzed by Western blot.
###end p 73
###begin title 74
Real time RT-PCR
###end title 74
###begin p 75
###xml 322 328 322 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRABP2</italic>
###xml 336 370 336 370 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TTG AGG AGC AGA CTG TGG ATG-3&#8242;</named-content>
###xml 382 416 382 416 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TTG GTC AGT TCT CTG GTC CAC-3&#8242;</named-content>
###xml 419 427 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 436 472 433 469 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GAC TGT ATG GAT GTT CTG TCA G-3&#8242;</named-content>
###xml 485 521 482 518 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- ATT TGT CCT GGC AGA CGA AGC A-3&#8242;</named-content>
###xml 524 529 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 538 571 535 568 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGT ACT GGA AGA TGT TGG TC-3&#8242;</named-content>
###xml 583 616 580 613 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CAT CTC TAG GTG CAG CTC AT-3&#8242;</named-content>
###xml 619 626 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 663 696 660 693 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCA ATC TTC AAC CGA ACT CC-3&#8242;</named-content>
###xml 709 745 706 742 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CTC CTT AAT AAC ACA CCC GAT G-3&#8242;</named-content>
###xml 752 757 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 766 798 763 795 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GAA GGT GAA GGT CGG AGT C-3&#8242;</named-content>
###xml 811 844 808 841 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GAA GAT GGT GAT GGG ATT TC-3&#8242;</named-content>
###xml 921 926 918 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1041 1042 1038 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Total RNA was obtained using Trizol (Invitrogen), treated with DNase I (Ambion, Austin, TX) and retrotranscribed with SuperScript First-Strand Synthesis System (Invitrogen). cDNA was amplified by Real-time RT-PCR on an iCycler (Bio-Rad, Hercules, CA) by using the iQ SYBR Green Supermix (Bio-Rad) and specific primers for CRABP2 (sense 5'- TTG AGG AGC AGA CTG TGG ATG-3', antisense 5'- TTG GTC AGT TCT CTG GTC CAC-3'), RARbeta2 (sense: 5'- GAC TGT ATG GAT GTT CTG TCA G-3'; antisense: 5'- ATT TGT CCT GGC AGA CGA AGC A-3'), CRBP1 (sense: 5'- GGT ACT GGA AGA TGT TGG TC-3', antisense 5'- CAT CTC TAG GTG CAG CTC AT-3'), CYP26A1 transcript variants 1 and 2 (sense: 5'- GCA ATC TTC AAC CGA ACT CC-3'; antisense: 5'- CTC CTT AAT AAC ACA CCC GAT G-3'), and GAPDH (sense: 5'- GAA GGT GAA GGT CGG AGT C-3'; antisense: 5'- GAA GAT GGT GAT GGG ATT TC-3'). The level of the different transcripts was normalized to the level of the GAPDH transcript, and quantified by the threshold cycle Ct method. Statistical significance was calculated by Student's t-test on three independent determinations; p values at least <0.05 were considered as significant.
###end p 75
###begin title 76
Quantitative chromatin immunoprecipitation (qChIP)
###end title 76
###begin p 77
###xml 332 340 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 346 349 343 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Ren1">[9]</xref>
###xml 358 396 355 393 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGT TCA CCG AAA GTT CAC TCG CAT-3&#8242;</named-content>
###xml 409 437 406 434 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CAGGCTTGCTCGGCCAATCCA-3&#8242;</named-content>
###xml 444 449 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 455 458 452 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Bistulfi1">[7]</xref>
###xml 466 502 463 499 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AGC CTG CAC TGT GAG AAC ACA T-3&#8242;</named-content>
###xml 514 551 511 548 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CCA CCA AGT AGA TGA CAT AAT CA-3&#8242;</named-content>
###xml 567 574 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 596 630 593 627 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGA GCT CAG CAC ACC TTG GAT-3&#8242;</named-content>
###xml 645 678 642 675 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CCA GGT TGC TGC CCA CGT TA-3&#8242;</named-content>
###xml 695 702 692 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 724 758 721 755 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GAG TTC ACT CGG ATG TCA CGG-3&#8242;</named-content>
###xml 773 806 770 803 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CTT TCT GGA CAG CGC CTC CG-3&#8242;</named-content>
###xml 989 994 986 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1019 1053 1016 1050 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGT GCG TGC CCA GTT GAA CCA-3&#8242;</named-content>
###xml 1066 1106 1063 1103 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AAA GAA GAT GCG GCT GAC TGT CGA A-3&#8242;</named-content>
ChIP was performed using reagents purchased from Upstate (Lake Placid, NY), according to the manufacturer's protocol. Chromatin was immunoprecipitated with antibodies against either acetyl-histone H4 or Polymerase II (both from Upstate), and DNA amplification was carried out by real time-PCR with specific primers encompassing the RARbeta2 RARE [9] (sense: 5'- GGT TCA CCG AAA GTT CAC TCG CAT-3'; antisense: 5'- CAGGCTTGCTCGGCCAATCCA-3'), the CRBP1 RARE [7] (sense 5'- AGC CTG CAC TGT GAG AAC ACA T-3', antisense 5'- CCA CCA AGT AGA TGA CAT AAT CA-3'), the proximal CYP26A1 RARE (P-RARE) (sense 5'- GGA GCT CAG CAC ACC TTG GAT-3' and antisense 5'- CCA GGT TGC TGC CCA CGT TA-3'), or the distal CYP26A1 RARE (D-RARE) (sense 5'- GAG TTC ACT CGG ATG TCA CGG-3' and antisense 5'- CTT TCT GGA CAG CGC CTC CG-3'). The relative enrichment of immunoprecipitated DNA was calculated by normalizing the PCR signals of the samples to both the input and the no antibody controls. Amplification of the GAPDH promoter region (sense: 5'- GGT GCG TGC CCA GTT GAA CCA-3'; antisense: 5'- AAA GAA GAT GCG GCT GAC TGT CGA A-3') was used as an internal control. Statistical significance was calculated by Student's t-test on three independent determinations; p values at least <0.05 were considered as significant.
###end p 77
###begin title 78
DNA methylation analysis
###end title 78
###begin p 79
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Herman1">[21]</xref>
###xml 360 368 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;2</italic>
###xml 426 459 423 456 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GTC GAG AAC GCG AGC GAT TC-3&#8242;</named-content>
###xml 477 510 474 507 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CGA CCA ATC CAA CCG AAA CG-3&#8242;</named-content>
###xml 512 515 509 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Ren1">[9]</xref>
###xml 517 521 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004305-Sirchia1">[11]</xref>
###xml 527 532 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRBP1</italic>
###xml 632 673 629 670 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CGT TTT TGC GTT CGT TTT CGT TAA GC-3&#8242;</named-content>
###xml 692 734 689 731 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AAA TAA CTA AAA CCA ATT AAC CAC AAA-3&#8242;</named-content>
###xml 745 782 742 779 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CGT TGC GTT TTG GGC GTT TCG TC-3&#8242;</named-content>
###xml 801 837 798 834 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CAC CAA ACC ACA ACT CAC CAA A-3&#8242;</named-content>
###xml 1201 1237 1198 1234 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TAT TAY GTG GAA GAG AGT TTA T-3&#8242;</named-content>
###xml 1257 1291 1254 1288 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- ACT TCA ACA AAA ACC CAA AAC-3&#8242;</named-content>
###xml 1367 1399 1364 1396 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GAA GGT TAG AGT TTG GAA TTT-3&#8242;</named-content>
###xml 1419 1453 1416 1450 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CCT ACA ATA CCA TCT ACA AAA-3&#8242;</named-content>
###xml 1820 1852 1817 1849 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TCG GCG CGG AAT AAA CGG T-3&#8242;</named-content>
###xml 1872 1905 1869 1902 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CGC GCC GCG ACC TCC CGC GC-3&#8242;</named-content>
###xml 1986 1993 1983 1990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP26A1</italic>
###xml 2071 2105 2068 2102 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TTA GTG AAG GTT GTT TTG GGT-3&#8242;</named-content>
###xml 2110 2144 2107 2141 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AAT ACA AAT CCC AAA ACT TAA-3&#8242;</named-content>
###xml 959 967 <span type="species:ncbi:274808">Searcher</span>
Genomic DNA was extracted with DNAzol (Invitrogen) according to the manufacturer's instructions. DNA was modified by sodium bisulfite treatment as previously described [21] and used for either bisulfite sequencing or quantitative Methylation Specific PCR (qMSP) by real time PCR with iQ SYBR Green Supermix (Bio-Rad, Hercules, CA) on an iCycler (Bio-Rad). For RARbeta2 qMSP we used a previously described primer set (M4 sense 5'- GTC GAG AAC GCG AGC GAT TC-3' and M4 antisense 5'- CGA CCA ATC CAA CCG AAA CG-3') [9], [11]. For CRBP1 qMSP we used the following primers, specifically amplifying two methylated CRBP1 regions: M1 sense 5'- CGT TTT TGC GTT CGT TTT CGT TAA GC-3' and AS1 antisense 5'- AAA TAA CTA AAA CCA ATT AAC CAC AAA-3'; M2 sense 5'- CGT TGC GTT TTG GGC GTT TCG TC-3' and AS2 antisense 5'- CAC CAA ACC ACA ACT CAC CAA A-3'. For CYP26A1, the 5' region of the gene was first analyzed for the presence of canonical CpG Islands by using CpG Island Searcher (). For bisulfite sequencing of the CpG island containing the proximal RARE, bisulfite modified DNA was amplified by nested PCR with Platinum Taq (Invitrogen). The first PCR round was performed with the following primers: P772 sense 5'- TAT TAY GTG GAA GAG AGT TTA T-3' and P773 antisense 5'- ACT TCA ACA AAA ACC CAA AAC-3'. The second PCR round was performed with the following primers: P776 sense 5'GAA GGT TAG AGT TTG GAA TTT-3' and P775 antisense 5'- CCT ACA ATA CCA TCT ACA AAA-3'. The PCR product was gel-purified and sequenced. For qMSP of the proximal CpG island, bisulfite modified DNA was amplified by nested PCR. The first PCR round was performed as described for bisulfite sequencing. The second round was performed by real time PCR with iQ SYBR Green Supermix (Bio-Rad) in combination with primers specific for methylated CpGs (P764 sense 5'- TCG GCG CGG AAT AAA CGG T-3' and P765 antisense 5'- CGC GCC GCG ACC TCC CGC GC-3'). The PCR signal from the M alleles was normalized to the signal from a control CYP26A1 region amplified by using primers that do not recognize any CpG (P774 sense: 5'- TTA GTG AAG GTT GTT TTG GGT-3' and 5'- AAT ACA AAT CCC AAA ACT TAA-3'). Statistical significance was calculated by Student's t-test on three independent determinations; p values at least <0.05 were considered as significant.
###end p 79
###begin title 80
Supporting Information
###end title 80
###begin p 81
Development of CRABP2 knock down clones. (A) Scheme of the short hairpin (sh) RNA sequences cloned into the pSUPER vector and subsequently used for HME1 stable transfection (left). Transient co-transfection experiments followed by WB analysis showing that the CRABP2-targeting sequences CRABP2-A and CRABP2-C, but not the scrambled sequence Mock, can effectively decrease the protein level of exogenous CRABP2 (right). (C) Sequencing analyses showing that the stable clones Si-CRABP2-A6, Si-CRABP2-C6 and Mock-13 contain the correct p-SUPER construct.
###end p 81
###begin p 82
(0.76 MB DOC)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 322 327 <span type="species:ncbi:9606">human</span>
CYP26A1 downregulation in human cells with an impaired RA-RARalpha signaling is marked by epigenetic chromatin changes. (A) Hampering RA availability at RARalpha by treatment with the RARalpha-specific antagonist ER50891 can significantly antagonize RA-induced transcription of both RARbeta2 (top) and CYP26A1 (bottom) in human cells (T47D). (B) T47D cells stably expressing a RARalpha dominant negative protein (DNC8), and cognate control cells (LXC5), are CRABP2-positive (top). (C) Impairment of RARalpha function in DNC8 cells significantly downregulates RA-induced transcription of both RARbeta2 (left) and CYP26A1 (right) relative to control LXC5 cells. (D) CYP26A1 transcriptional repression in DNC8 cells is associated with significant histone H4 hypoacetylation, unresponsive to RA, at the CYP26A1 regions encompassing either the distal RARE (D-RARE), or the proximal RARE (P-RARE). (E) Treatment of DNC8 cells with either TSA (24 h), or 5- Aza (72 h) can restore RA-induced transcription from both RARbeta2 (left) and CYP26A1 (right).
###end p 84
###begin p 85
(3.50 MB TIF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 121 129 <span type="species:ncbi:274808">Searcher</span>
In silico identification of human CYP26A1 CpG islands. Analysis of the CYP26A1 5' regulatory regions by using CpG Island Searcher identifies two CpG islands: one containing the distal RARE (D-RARE), from -2086 to -1502, and one containing the proximal RARE (P-RARE), from -375 to +2239.
###end p 87
###begin p 88
(9.31 MB TIF)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
We wish to thank Dr. Noa Noy (Case Western Reserve University, Cleveland, OH) for providing us with the CRABP2 mutant CRABP2-KRK, and John Fischer (Roswell Park Cancer Institute) for technical help.
###end p 90
###begin title 91
References
###end title 91
###begin article-title 92
Overview of retinoid metabolism and function.
###end article-title 92
###begin article-title 93
Retinoic acid: its biosynthesis and metabolism.
###end article-title 93
###begin article-title 94
A decade of molecular biology of retinoic acid receptors.
###end article-title 94
###begin article-title 95
Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription.
###end article-title 95
###begin article-title 96
Nuclear retinoid receptors and the transcription of retinoid-target genes.
###end article-title 96
###begin article-title 97
Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells.
###end article-title 97
###begin article-title 98
A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation. Implications for breast cancer risk.
###end article-title 98
###begin article-title 99
RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells.
###end article-title 99
###begin article-title 100
Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance.
###end article-title 100
###begin article-title 101
Retinoic acid hydroxylase (CYP26) is a key enzyme in neuronal differentiation of embryonal carcinoma cells.
###end article-title 101
###begin article-title 102
Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
###end article-title 102
###begin article-title 103
Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest.
###end article-title 103
###begin article-title 104
A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II.
###end article-title 104
###begin article-title 105
The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells.
###end article-title 105
###begin article-title 106
Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid.
###end article-title 106
###begin article-title 107
Transcriptional co-operativity between distant retinoic acid response elements in regulation of Cyp26A1 inducibility.
###end article-title 107
###begin article-title 108
Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism.
###end article-title 108
###begin article-title 109
Altered methylation patterns in cancer cell genomes: cause or consequence?
###end article-title 109
###begin article-title 110
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.
###end article-title 110
###begin article-title 111
Syntheses and evaluation of quinoline derivatives as novel retinoic acid receptor alpha antagonists.
###end article-title 111
###begin article-title 112
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
###end article-title 112
###begin p 113
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 113
###begin p 114
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the NCI R01-CA127614-01A2 grant (NS). GB and FC were supported by the Predoctoral US Army Award W81XWH0510222 and the University of Milan Foreign Exchange Program, SR was supported by a postdoctoral Susan Komen Foundation award.
###end p 114

